← k3vl4r
Log inGet started →

ACAD (Acadia Pharmaceuticals Inc) Price Forecast

AI-generated price forecast for Acadia Pharmaceuticals Inc (ACAD) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ACAD as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 18.32. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

18.32

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

ACAD forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-26.63%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ACAD's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ACAD news

From the market-news feed the forecasts are read against.

  • ACADIA Pharmaceuticals Eyes Deals as DAYBUE Growth Fuels Revenue Surge · ldr:marketbeat.com · Nov 17
  • Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer's Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference · Yahoo · Nov 17
  • Acadia Pharmaceuticals Inc. (ACAD) Presents at UBS Global Biopharma Conference 2026 Transcript · SeekingAlpha · Nov 17
  • Acadia Pharmaceuticals Enters Exclusive Distribution Agreement with KYORIN Pharmaceutical for DAYBUE® STIX (trofinetide) in Japan · Yahoo · Nov 16
  • Morgan Stanley Maintains Equal-Weight on Acadia Pharmaceuticals, Lowers Price Target to $24 · Benzinga · Nov 13

🔒

See the full ACAD forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ACAD forecast — frequently asked

Will ACAD go up?

K3vl4r's calibrated AI forecast currently reads ACAD as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ACAD price prediction for 2026?

K3vl4r's model projects ACAD toward $13.44 over the next ~4 weeks, a -26.6% move from $18.32. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

KTTAAUTLEBSGMABZYMEIONSANABVYGRSNNPIIINMRABRTXDNLIIFRX

Will ACAD reach…?

Will ACAD reach $25.00?Will ACAD reach $50.00?Will ACAD reach $100.00?

Or see the full ACAD price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ACAD

ACAD vs KTTAACAD vs AUTLACAD vs EBSACAD vs GMABACAD vs ZYMEACAD vs IONS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.